Leuko
Alvaro Sanchez-Ferro is the co-founder and Chief Medical Officer of Leuko, a startup focused on improving care for cancer patients with neutropenia. Alvaro is also a Neurologist at Hospital 12 de Octubre, specializing in Movement Disorders. In addition, Alvaro holds various leadership roles in organizations such as the International Parkinson and Movement Disorder Society and the Movement Disorders Journal. Alvaro has a strong background in research and academia, having completed fellowships at institutions like Massachusetts Institute of Technology and Massachusetts General Hospital. Alvaro holds a Doctor of Medicine degree from Universidad Autonoma de Madrid and has pursued further education in research methodology and clinical genetics.
This person is not in any offices
Leuko
Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is the first-line indicator for various medically relevant situations, ranging from chemotherapy management to the detection of life-threatening infections worldwide.